Remote rehabilitation after ICU (iRehab)

• Research type

  Research Study

• Full title

  Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge: a randomised controlled assessor-blind clinical and cost-effectiveness trial with internal pilot (iRehab).

• IRAS ID

  310777

• Contact name

  Brenda O'Neill

• Contact email

  b.oneill@ulster.ac.uk

• Sponsor organisation

  Ulster University

• ISRCTN Number

  ISRCTN11266403

• Duration of Study in the UK

  2 years, 11 months, 31 days

• Research summary

  We need to find out if a rehabilitation programme will help patients following intensive care who are discharged from hospital.

  The objective of this trial is to investigate, in survivors of critical illness following discharge from hospital after an Intensive Care Unit (ICU) admission, the effects of a six-week remote multicomponent rehabilitation intervention compared to standard care on health-related quality of life at eight weeks post-randomisation.

  The intervention group will receive a six-week remote rehabilitation programme. The intervention can be delivered over video or telephone. It includes: 1) weekly individual appointment with a member of the iRehab team; 2) home-based exercise sessions; 3) weekly online peer support session. The control group will receive standard care and will not be required to undertake a rehabilitation programme.

  We will compare the quality of life, physical strength, and emotional wellbeing of the patients who take part in the rehabilitation programme with the patients who do not. We will also ask patients about their tiredness, views about illness, and anxiety levels. This information will be collected when participants join the study, at eight weeks and at 6 months by researchers not involved in the rehabilitation. The primary outcome is health-related Quality of Life: EQ-5D-5L at eight weeks. Additionally, we will be looking at value for money.

  At the end of the trial, we will share our findings with other ICUs, clinicians, researchers, and patient groups to help improve patient care.

• REC name

  London - Central Research Ethics Committee

• REC reference

  22/LO/0314

• Date of REC Opinion

  19 May 2022

• REC opinion

  Further Information Favourable Opinion